Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine with Mitoxantrone and Etoposide in Refractory AML
NCT00002688Phase 2Unknown
- Sponsor
- University Medical Center Groningen
- Start
- Feb 1995
- Modality
- Peptides, Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, open-label trial of cyclosporine in acute myeloid leukemia (AML) (2 arms), sponsored by University Medical Center Groningen. Primary endpoints: Response Rate and Duration of Response. Status: unknown.
02
Drugs
cyclosporine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00002688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002688.